source
- Bristol Myers turns focus to AI costs after broad rollout to workersPALO ALTO, CA — After giving artificial intelligence tools to thousands of employees, Bristol Myers Squibb is now working to get a handle on the costs of the technology and where it’s actually crea…Endpoints · 1mo ago↗ source
- Axsome pushes back generic entry for narcolepsy drug until 2040Axsome Therapeutics has successfully delayed generic competition for its narcolepsy drug Sunosi until 2040. The company announced on Wednesday that it has reached a settlement with the last applica…Endpoints · 1mo ago↗ source
- FDA guides pharma on explaining unapproved drugs to payorsBiopharma companies preparing to launch the next practice-changing blockbusters want payors to know what's coming before they ultimately land an FDA approval. The trick is to do that without stretc…